June 1, 2017 / 8:45 AM / 2 months ago

BRIEF-Spectracure gets patent for dose control in Canada

1 Min Read

June 1 (Reuters) - SPECTRACURE AB (PUBL):

* Gets Patent for Dose Control in Canada

* CANADIAN PATENT OFFICE APPROVED PATENT FOR DOSE CONTROL IN A TECHNOLOGY AIMED TO CURE PROSTATE CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below